While Zenas’ obexelimab hit the primary endpoint in the Phase III INDIGO study, it came far below the efficacy threshold set by Amgen’s B cell depleter Uplizna, approved by the FDA for IgG4-related ...

Every retired athlete, whether you played in high school, college or got to the pros, knows how hard it is to hang up your jersey when the game is done with you. You can look at old pictures, you can ...

TOKYO (AP) — Anna Hall is the first to admit that the injuries, the excruciating losses and the hours of practice when she felt like she was going nowhere pushed her to lose her love for track and ...

TOKYO -- Anna Hall is the first to admit that the injuries, the excruciating losses and the hours of practice when she felt like she was going nowhere pushed her to lose her love for track and field.